David Ternant
17PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|Aug 14, 2025
Immunoglobulin G Receptors (FcγR), in Addition to Target-Antigen and Neonatal Fc Receptor (FcRn), Influence Rituximab Pharmacokinetics.David Ternant, Olivier Le Tilly, Guillaume Cartron
|Jun 17, 2024
Population pharmacokinetics of mycophenolate in patients treated for interstitial lung disease (EVER-ILD study).Yan-Min Xu, David Ternant, Martine Reynaud-Gaubert
|Dec 10, 2023
Confounding mitigation for the exposure-response relationship of bevacizumab in colorectal cancer patients.Sarah Lobet, Morgane Caulet, Gilles Paintaud
|Aug 26, 2023
Translation of Monoclonal Antibodies Pharmacokinetics from Animal to Human Using Physiologically Based Modeling in Open Systems Pharmacology (OSP) Suite: A Retrospective Analysis of Bevacizumab.Blaise Pasquiers, Salih Benamara, Mathieu Felices
|Jul 13, 2023
Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients.Sarah Lobet, Gilles Paintaud, Nicolas Azzopardi
|Jan 19, 2022
Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition model.Olivier Le Tilly, Philippe Gatault, Christophe Baron
Pageof 3
Frequent Collaborators
2 joint publications
Theodora Bejan-Angoulvant
2 joint publications
Céline Desvignes
1 joint publications
Thierry Lecomte
1 joint publications
Astrid Lièvre
1 joint publications
Marc Ohresser
1 joint publications
Romain Chautard
1 joint publications
William Raoul
1 joint publications
Gilles Paintaud
1 joint publications
Denis Mulleman
1 joint publications
Olivier Le Tilly
